|
| | CIMICIFUGOSIDE Basic information |
| Product Name: | CIMICIFUGOSIDE | | Synonyms: | CIMICIFUGOSIDE;Prim-O-glucosylcimifygin;β-D-Xylopyranoside, (3β,12β,16β,23R,24R,25S)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanost-7-en-3-yl;CIMICIFUGOSIDE USP/EP/BP | | CAS: | 66176-93-0 | | MF: | C37H54O11 | | MW: | 674.82 | | EINECS: | | | Product Categories: | Miscellaneous Natural Products | | Mol File: | 66176-93-0.mol |  |
| | CIMICIFUGOSIDE Chemical Properties |
| density | 1.38±0.1 g/cm3(Predicted) | | pka | 12.14±0.70(Predicted) |
| | CIMICIFUGOSIDE Usage And Synthesis |
| Biological Activity | Cimicifugoside, a triterpenoid extracted from Cimicifuga simplex, is a novel specific nucleoside transport inhibitor that synergistically enhances the cytotoxic effect of methotrexate. It has immunosuppressive activity that preferentially targets B cell function, requiring larger doses to inhibit T cell function. | | target | |
| | CIMICIFUGOSIDE Preparation Products And Raw materials |
|
